Armistice Capital, Llc

13F Holdings History for Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDX)

Symbol: AXDX on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 1.88M shares
Security Ownership: 7.45%

Shares, Excluding Options vs Price

Value, Excluding Options

Armistice Capital, LLC ownership in Accelerate Diagnostics, Inc Common Stock, $0.001 par value per share (AXDX)

2025-05-15 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.88M shares of Accelerate Diagnostics, Inc Common Stock, $0.001 par value per share (AXDX). This represents 7.45% percent ownership of the company. In their previous filing dated 2025-02-14, ARMISTICE CAPITAL, LLC had reported owning 2.08M shares, indicating a decrease of -9.57% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Armistice Capital, LLC	7.45%	-10%	$1.32M	1.88M	-198,773	-9.57%	$0.70	13G/A	3/31/2025	15 May 2025 15:23:06
Armistice Capital, LLC	8.25%		$1.46M	2.08M			$0.70	13G/A	12/31/2024	14 Feb 2025 16:50:08

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025		-0.04%	$0	0	-1,879,227	-100%		Q2 2025
3/31/2025	0.04%	0%	$1.32M	1.88M	-198,773		$0.70	Q1 2025
12/31/2024	0.06%	0%	$2.49M	2.08M	-23,000	-1.09%	$1.20	Q4 2024
9/30/2024	0.09%	+0.02%	$3.59M	2.1M	+493,000	+30.7%	$1.71	Q3 2024
6/30/2024	0.05%	-0.01%	$1.88M	1.61M	-238,000	-12.9%	$1.17	Q2 2024
3/31/2024	0.05%	+0.02%	$1.83M	1.85M	+1,846,000	NEW	$0.99	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.